Literature DB >> 26660713

Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series.

Nancy Rivas-Tolosa1, Ariadna Ortiz-Brugués2, Tomás Toledo-Pastrana3, Manel Baradad2, Víctor Traves4, Virtudes Soriano5, Verónica Sanmartín2, Celia Requena1, Rosa Martí2, Eduardo Nagore1.   

Abstract

Locoregional cutaneous metastases of melanoma (LCMM) represent a therapeutic challenge. Many treatment options are available with varying results. The combination of cryotherapy and imiquimod, two treatments with a possible synergistic effect, has not yet been described for treating this disease. In this paper, we aimed to show the response of LCMM to cryotherapy combined with topical imiquimod 5%. A retrospective review of 20 patients diagnosed with LCMM and treated with cryotherapy combined with topical imiquimod 5% between November 2000 and May 2014 at three institutions was performed. The locoregional cutaneous response was evaluated. After a mean of five sessions, 13 patients (65%) responded to treatment, eight (40%) of these completely and five (25%) partially. Systemic disease progressed in 16 (80%) patients. Cryotherapy followed by topical imiquimod 5% is simple to apply, has minimal adverse effects and provides response rates similar to other, more complex treatment options.
© 2015 Japanese Dermatological Association.

Entities:  

Keywords:  cryotherapy; imiquimod; locoregional cutaneous metastases; melanoma; treatment

Mesh:

Substances:

Year:  2015        PMID: 26660713     DOI: 10.1111/1346-8138.13197

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

1.  Advancements in unresectable melanoma: a multidisciplinary perspective.

Authors:  Mary-Kate Malecek; June K Robinson; Karl Bilimoria; Jennifer N Choi; Jaehyuk Choi; Pedram Gerami; Timothy Kruser; Timothy Kuzel; Mary Martini; Jonathan B Strauss; Jeffrey Wayne; Jeffrey Sosman; Sunandana Chandra
Journal:  Melanoma Manag       Date:  2016-08-16

Review 2.  Melanoma and Immune Checkpoint Inhibitors.

Authors:  Masutaka Furue; Takamichi Ito; Naoko Wada; Maiko Wada; Takafumi Kadono; Hiroshi Uchi
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

3.  Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma.

Authors:  Jennifer E Yeh; Marilyn T Wan; Allireza Alloo; Nageatte Ibrahim; Patrick A Ott; Elizabeth I Buchbinder; Jennifer Y Lin
Journal:  JAAD Case Rep       Date:  2022-07-22

Review 4.  Advanced Acral Melanoma Therapies: Current Status and Future Directions.

Authors:  Yiqun Zhang; Shijie Lan; Di Wu
Journal:  Curr Treat Options Oncol       Date:  2022-09-20

5.  Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.

Authors:  Hansje-Eva Teulings; Esther P M Tjin; Karina J Willemsen; Stephanie van der Kleij; Sylvia Ter Meulen; E Helen Kemp; Gabrielle Krebbers; Carel J M van Noesel; Cornelis L M C Franken; Jan W Drijfhout; Cornelis J M Melief; Ludmila Nieuweboer-Krobotova; Omgo E Nieweg; Jos A van der Hage; J P Wietze van der Veen; Germaine N Relyveld; Rosalie M Luiten
Journal:  Oncoimmunology       Date:  2018-01-15       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.